dHMN-COQ7

COQ7 | 2023

What Is dHMN-COQ7?

dHMN-COQ7 is a type of CMT caused by autosomal recessive mutations in the COQ7 gene. This gene provides instructions for making an enzyme required for the production of coenzyme Q10, a molecule essential to cellular energy metabolism. Mutations in the COQ7 gene disrupt this function, leading to impaired nerve signal transmission.

dHMN-COQ7 is autosomal recessive, meaning that both copies of the gene must have a mutation to cause this subtype.

Clinical Features

The age of symptom onset in dHMN-COQ7 is variable, ranging from childhood to adulthood. As a motor neuropathy, dHMN-COQ7 primarily affects the most distal points, with weakness and atrophy of the feet and hands, and little to no involvement of the sensory nerves. Nerve conduction studies usually show somewhat slowed conduction velocities and reduced amplitudes, consistent with an axonal form of CMT.

dHMN-COQ7 symptoms may include:

  • Weakness and atrophy in the feet and lower legs
  • Foot drop
  • Reduced or absent reflexes
  • A steppage-style walking pattern
  • Foot deformities, including high arches, and hammertoes (clawed toes)
  • Progressive involvement of the hands
  • Difficulty with fine motor skills and manual dexterity
  • Additional symptoms not listed here

Disease Course

dHMN-COQ7 shows wide variability in severity and progression. Some individuals are mildly affected, while others develop a more severe disease. Disease progression is generally slow, and life expectancy is not reduced.

Clinical Basics

Subtype
dHMN-COQ7

Classification
dHMN/HMN

Subtype Alias
HMNR9

Neuropathy Type
Axonal

Inheritance Pattern
autosomal recessive

Genetic Context

HGNC-Approved Gene Symbol
COQ7

Gene Full Name
Coenzyme Q7, Hydroxylase

HGNC Gene Alias(es)
CLK1

Chromosome
16p12.3

Zygosity of Responsible Variant
Homozygous or Compound Heterozygous

Mitochondrial Involvement
Yes

Variant Mechanism
Loss of Function (LoF)

ClinVar Pathogenic Variants

View dHMN-COQ7 ClinVar Variants

dHMN-COQ7 OMIM Entry

dHMN-COQ7 OMIM

COQ7 OMIM Entry

COQ7 OMIM

More Info

dHMN-COQ7 Research Opportunity

CMT Natural History Study

Original Discovery Publication

Publication Title

Biallelic Variants in COQ7 Cause Distal Hereditary Motor Neuropathy with Uupper Motor Neuron Signs

Authors

Rebelo, A. P., Tomaselli, P. J., Medina, J., Wang, Y., Dohrn, M. F., Nyvltova, E., Danzi, M. C., Garrett, M., Smith, S. E., Pestronk, A., Li, C., Ruiz, A., Jacobs, E., Feely, S. M. E., França, M. C., Gomes, M. V., Santos, D. F., Kumar, S., Lombard, D. B., Saporta, M., Hekimi, S., Barrientos, A., Weihl, C., Shy, M.E., Marques, W., Zuchner, S.

Publication Date
October 1, 2023

Updated: July 18, 2026 | By: K. Raymond

The Dorsal Root

More From The Dorsal Root


Close-up of a doctor’s hand holding a prescription pad while a patient’s wrist is wrapped with metal chains.


When Medicine Lost Its Compass

Evidence failed not because it was wrong, but because it was weaponized. I lived the downstream effects of that failure for more than a decade. This is what happens when medicine forgets that data always ends in a human being.


Illustrated graphic showing large ‘404’ numerals with people interacting with data screens and servers, alongside text reading ‘CMT Genetic Testing Error 404: Gene Not Found’ and ‘Examining Why Less Than Half of All Who Have Charcot-Marie-Tooth Disease Are Not Able to Obtain Genetic Confirmation of Their Disease.


Error 404: Gene Not Found

CMT genetic testing often fails to identify the cause of the disease, even when comprehensive panels are used. Here, we discuss why this happens, what genetic tests can and cannot do, and why a negative result still matters.


Illustrated cover graphic showing a split landform with branching directional arrows, two people with question marks above their heads, and the title ‘SORD Deficiency: Decoding This Newly Discovered and Confusing CMT Subtype.


CMT-SORD: What Is This Unique CMT Subtype?

CMT-SORD is a newly discovered CMT subtype driven by toxic sorbitol accumulation. This article explains how "SORD" works, why this subtype is different, and how it led to the fastest-moving therapeutic program in CMT history.